Mariluz López-Rodríguez

UCM707, an inhibitor of the anandamide uptake, behaves as a symptom control agent in models of Huntington's disease and multiple sclerosis, but fails to delay/arrest the progression of different motor-related disorders

D. Baker, J. Ramos, J. Fernández-Ruiz, 2006, European Neuropsychopharmacology.